Myezom 2mg Injection

Product Description

1. Technical Specifications

---

2. Product Description

Myezom 2 mg Injection contains Bortezomib, a proteasome inhibitor used in oncology.
It disrupts the 26S proteasome, an enzyme complex responsible for protein degradation in cells. By inhibiting this, bortezomib leads to accumulation of proteins within cancer cells, triggering apoptosis (cell death).
It is primarily prescribed for Multiple Myeloma and Mantle Cell Lymphoma (MCL).

---

3. Product Highlights

---

4. Therapeutic Uses

• Multiple Myeloma (first-line and relapsed/refractory cases, often in combination with other drugs like dexamethasone, cyclophosphamide, or lenalidomide).

• Mantle Cell Lymphoma (MCL) in patients previously treated with at least one therapy.

---

5. Side Effects

Common:

• Fatigue, weakness

• Nausea, vomiting, diarrhea, constipation

• Loss of appetite

• Fever, infections

• Thrombocytopenia, neutropenia, anemia

• Peripheral neuropathy (numbness/tingling in hands & feet)

Serious:

• Severe peripheral neuropathy

• Heart problems (heart failure, hypotension)

• Pulmonary toxicity (shortness of breath, interstitial lung disease)

• Hepatotoxicity

• Tumor lysis syndrome

• Severe infections (sepsis, pneumonia)

---

6. Precautions

• Blood Counts: Regular CBC monitoring required due to risk of cytopenias.

• Neuropathy: Dose modification or discontinuation may be needed in severe cases.

• Cardiac Patients: Use with caution in those with heart disease or hypotension.

• Liver & Kidney Function: Dose adjustments may be required in hepatic impairment; monitor renal function.

• Pregnancy & Breastfeeding: Contraindicatedteratogenic risk; contraception is required during and after therapy.

• Drug Interactions: Caution with CYP3A4 inhibitors/inducers (ketoconazole, rifampicin, phenytoin, etc.).

Administered by Professionals

Myezom 2mg Injection is designed for administration only under the supervision of qualified healthcare personnel. It ensures patients benefit from precise dosing and professional monitoring, enhancing treatment outcomes. Its use is best reserved for clinical environments where accurate administration protocols can be followed.


Storage and Care Guidelines

To maintain the integrity of Myezom 2mg Injection, it should always be stored in a cool, dry environment away from direct light or moisture. Following these storage instructions helps preserve the medications potency and ensure its safety throughout its shelf life.


Targeted for Medical Distribution

This injectable medication is available through reputable distributors, suppliers, exporters, traders, and wholesalers within India. Its distribution is strictly regulated to ensure that it reaches only authorized medical professionals and healthcare institutions.